Modelled DT Structure
Method: homology modeling
Template PDB: 5UJ9_A
Identity: 47.479%
Minimized Score: -3170.846 kcal/mol
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0017 | ||||
Gene Name | ABCC6 | ||||
Protein Name | Multidrug resistance-associated protein 6 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 5UJ9_A Identity: 47.479% Minimized Score: -3170.846 kcal/mol Detail: Structure Info |
||||
Synonyms | ABC34; ABCC6; ARA; ATP-binding cassette sub-family C member 6; Anthracycline resistance-associated protein; EST349056; GACI2; MLP1; MOAT-E; MOATE; MRP6; Multi-specific organic anion transporter E; PXE; PXE1; URG7 | ||||
DT Family | ATP-Binding Cassette (ABC) Superfamily | ||||
Drug Conjugate Transporter (DCT) Family (ABCC) | |||||
Tissue Specificity | Expressed in kidney and liver. Very lowexpression in other tissues. | ||||
Function | This transporter may participate directly in the active transport of drugs into subcellular organelles or influence drug distribution indirectly. Transports glutathione conjugates as leukotriene-c4 (LTC4) and N-ethylmaleimide S-glutathione (NEM-GS). | ||||
Disease(s) | Gout [ICD-11: FA25] | ||||
Ovarian cancer [ICD-11: 2C73] | |||||
Endogenous Substrate(s) | DNP; Glutathione conjugates; N-ethylmaleimide S-glutathione; Organoanions; Leukotriene C4 | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(α) Microbiota Influence of This DT |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(α) Mutation-induced Structural Variation |
|||||
(β) Inter-species Structural Differences |
|||||
(γ) Outward/inward-facing Conformation |
|||||
(δ) Xenobiotics-regulated Structural Variability |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 3 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Benzbromarone
|
Approved | Drug Info | Gout | FA25 | [1] |
Cisplatin
|
Approved | Drug Info | Testicular cancer | 2C80 | [2] |
Daunorubicin
|
Approved | Drug Info | Acute myeloid leukemia | 2A60 | [2] |
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Epipodophyllotoxins
|
Preclinical | Drug Info | Molluscum contagiosum infection | 1.00E+76 | [2] |
Endogenous Metabolites (EMs) Handled by This DT |
|||||
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 16 EMs in Total | ||||
EM Name | PubChem CID | Detail | Experimental Material | Ref | |
2-hydroxy-3-methyl-butyric acid | EM Info | Identified using ABCC6-deficient mice | [3] | ||
3-dehydro-d-glucose 6-phosphate | EM Info | Identified using ABCC6-deficient mice | [3] | ||
3-sulfinoalanine | EM Info | Identified using ABCC6-deficient mice | [3] | ||
Adenosine monophosphate | EM Info | Identified using ABCC6-deficient mice | [3] | ||
Glutamate | EM Info | Identified using ABCC6-deficient mice | [3] | ||
Glutamine | EM Info | Identified using ABCC6-deficient mice | [3] | ||
Ile-Pro-Ile | EM Info | Identified using ABCC6-deficient mice | [3] | ||
N-acetylcitrulline | EM Info | Identified using ABCC6-deficient mice | [3] | ||
N-acetylglutamate | EM Info | Identified using ABCC6-deficient mice | [3] | ||
N-acetylmethionine | EM Info | Identified using ABCC6-deficient mice | [3] | ||
N-valylphenylalanine | EM Info | Identified using ABCC6-deficient mice | [3] | ||
Pantothenic acid | EM Info | Identified using ABCC6-deficient mice | [3] | ||
Pyridoxic acid | EM Info | Identified using ABCC6-deficient mice | [3] | ||
Succinyladenosine | EM Info | Identified using ABCC6-deficient mice | [3] | ||
Uridine | EM Info | Identified using ABCC6-deficient mice | [3] | ||
Xanthosine | EM Info | Identified using ABCC6-deficient mice | [3] | ||
References | |||||
1 | The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016 Jan 4;44(D1):D372-9. (ID: 3.A.1.208.10) | ||||
2 | Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res. 2002 Nov 1;62(21):6172-7. | ||||
3 | Untargeted Metabolomics Analysis of ABCC6-Deficient Mice Discloses an Altered Metabolic Liver Profile. J Proteome Res. 2016 Dec 2;15(12):4591-4600. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.